<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:10:29Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7581015" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7581015</identifier>
        <datestamp>2020-10-26</datestamp>
        <setSpec>acssd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" xml:lang="EN" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Anal Chem</journal-id>
              <journal-id journal-id-type="iso-abbrev">Anal Chem</journal-id>
              <journal-id journal-id-type="publisher-id">ac</journal-id>
              <journal-id journal-id-type="coden">ancham</journal-id>
              <journal-title-group>
                <journal-title>Analytical Chemistry</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0003-2700</issn>
              <issn pub-type="epub">1520-6882</issn>
              <publisher>
                <publisher-name>American Chemical
Society</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7581015</article-id>
              <article-id pub-id-type="pmcid">PMC7581015</article-id>
              <article-id pub-id-type="pmc-uid">7581015</article-id>
              <article-id pub-id-type="pmid">32961048</article-id>
              <article-id pub-id-type="doi">10.1021/acs.analchem.0c03129</article-id>
              <article-categories>
                <subj-group>
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Capillary Electrophoresis-Mass Spectrometry at Trial
by Metabo-Ring: Effective Electrophoretic Mobility for Reproducible
and Robust Compound Annotation</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes" id="ath1">
                  <name>
                    <surname>Drouin</surname>
                    <given-names>Nicolas</given-names>
                  </name>
                  <xref rid="cor1" ref-type="other">*</xref>
                  <xref rid="aff1" ref-type="aff">†</xref>
                  <xref rid="notes2" ref-type="notes">#</xref>
                </contrib>
                <contrib contrib-type="author" id="ath2">
                  <name>
                    <surname>van Mever</surname>
                    <given-names>Marlien</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">†</xref>
                  <xref rid="notes2" ref-type="notes">#</xref>
                </contrib>
                <contrib contrib-type="author" id="ath3">
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Wei</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">†</xref>
                </contrib>
                <contrib contrib-type="author" id="ath4">
                  <name>
                    <surname>Tobolkina</surname>
                    <given-names>Elena</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">‡</xref>
                  <xref rid="aff3" ref-type="aff">§</xref>
                </contrib>
                <contrib contrib-type="author" id="ath5">
                  <name>
                    <surname>Ferre</surname>
                    <given-names>Sabrina</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">‡</xref>
                  <xref rid="aff3" ref-type="aff">§</xref>
                </contrib>
                <contrib contrib-type="author" id="ath6">
                  <name>
                    <surname>Servais</surname>
                    <given-names>Anne-Catherine</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">∥</xref>
                </contrib>
                <contrib contrib-type="author" id="ath7">
                  <name>
                    <surname>Gou</surname>
                    <given-names>Marie-Jia</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">∥</xref>
                </contrib>
                <contrib contrib-type="author" id="ath8">
                  <name>
                    <surname>Nyssen</surname>
                    <given-names>Laurent</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">∥</xref>
                  <xref rid="aff5" ref-type="aff">⊥</xref>
                </contrib>
                <contrib contrib-type="author" id="ath9">
                  <name>
                    <surname>Fillet</surname>
                    <given-names>Marianne</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">∥</xref>
                </contrib>
                <contrib contrib-type="author" id="ath10">
                  <name>
                    <surname>Lageveen-Kammeijer</surname>
                    <given-names>Guinevere S.M.</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">@</xref>
                </contrib>
                <contrib contrib-type="author" id="ath11">
                  <name>
                    <surname>Nouta</surname>
                    <given-names>Jan</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">@</xref>
                </contrib>
                <contrib contrib-type="author" id="ath12">
                  <name>
                    <surname>Chetwynd</surname>
                    <given-names>Andrew J.</given-names>
                  </name>
                  <xref rid="aff7" ref-type="aff">⊖</xref>
                </contrib>
                <contrib contrib-type="author" id="ath13">
                  <name>
                    <surname>Lynch</surname>
                    <given-names>Iseult</given-names>
                  </name>
                  <xref rid="aff7" ref-type="aff">⊖</xref>
                </contrib>
                <contrib contrib-type="author" id="ath14">
                  <name>
                    <surname>Thorn</surname>
                    <given-names>James A.</given-names>
                  </name>
                  <xref rid="aff8" ref-type="aff">⦶</xref>
                </contrib>
                <contrib contrib-type="author" id="ath15">
                  <name>
                    <surname>Meixner</surname>
                    <given-names>Jens</given-names>
                  </name>
                  <xref rid="aff9" ref-type="aff">□</xref>
                </contrib>
                <contrib contrib-type="author" id="ath16">
                  <name>
                    <surname>Lößner</surname>
                    <given-names>Christopher</given-names>
                  </name>
                  <xref rid="aff10" ref-type="aff">■</xref>
                </contrib>
                <contrib contrib-type="author" id="ath17">
                  <name>
                    <surname>Taverna</surname>
                    <given-names>Myriam</given-names>
                  </name>
                  <xref rid="aff11" ref-type="aff">○</xref>
                  <xref rid="aff12" ref-type="aff">●</xref>
                </contrib>
                <contrib contrib-type="author" id="ath18">
                  <name>
                    <surname>Liu</surname>
                    <given-names>Sylvie</given-names>
                  </name>
                  <xref rid="aff11" ref-type="aff">○</xref>
                </contrib>
                <contrib contrib-type="author" id="ath19">
                  <name>
                    <surname>Tran</surname>
                    <given-names>N. Thuy</given-names>
                  </name>
                  <xref rid="aff11" ref-type="aff">○</xref>
                </contrib>
                <contrib contrib-type="author" id="ath20">
                  <name>
                    <surname>Francois</surname>
                    <given-names>Yannis</given-names>
                  </name>
                  <xref rid="aff13" ref-type="aff">△</xref>
                </contrib>
                <contrib contrib-type="author" id="ath21">
                  <name>
                    <surname>Lechner</surname>
                    <given-names>Antony</given-names>
                  </name>
                  <xref rid="aff13" ref-type="aff">△</xref>
                </contrib>
                <contrib contrib-type="author" id="ath22">
                  <name>
                    <surname>Nehmé</surname>
                    <given-names>Reine</given-names>
                  </name>
                  <xref rid="aff14" ref-type="aff">▲</xref>
                </contrib>
                <contrib contrib-type="author" id="ath23">
                  <name>
                    <surname>Al Hamoui Dit Banni</surname>
                    <given-names>Ghassan</given-names>
                  </name>
                  <xref rid="aff14" ref-type="aff">▲</xref>
                </contrib>
                <contrib contrib-type="author" id="ath24">
                  <name>
                    <surname>Nasreddine</surname>
                    <given-names>Rouba</given-names>
                  </name>
                  <xref rid="aff14" ref-type="aff">▲</xref>
                </contrib>
                <contrib contrib-type="author" id="ath25">
                  <name>
                    <surname>Colas</surname>
                    <given-names>Cyril</given-names>
                  </name>
                  <xref rid="aff14" ref-type="aff">▲</xref>
                  <xref rid="aff15" ref-type="aff">▽</xref>
                </contrib>
                <contrib contrib-type="author" id="ath26">
                  <name>
                    <surname>Lindner</surname>
                    <given-names>Herbert H.</given-names>
                  </name>
                  <xref rid="aff16" ref-type="aff">▼</xref>
                </contrib>
                <contrib contrib-type="author" id="ath27">
                  <name>
                    <surname>Faserl</surname>
                    <given-names>Klaus</given-names>
                  </name>
                  <xref rid="aff16" ref-type="aff">▼</xref>
                </contrib>
                <contrib contrib-type="author" id="ath28">
                  <name>
                    <surname>Neusüß</surname>
                    <given-names>Christian</given-names>
                  </name>
                  <xref rid="aff17" ref-type="aff">⬡</xref>
                </contrib>
                <contrib contrib-type="author" id="ath29">
                  <name>
                    <surname>Nelke</surname>
                    <given-names>Manuel</given-names>
                  </name>
                  <xref rid="aff17" ref-type="aff">⬡</xref>
                </contrib>
                <contrib contrib-type="author" id="ath30">
                  <name>
                    <surname>Lämmerer</surname>
                    <given-names>Stefan</given-names>
                  </name>
                  <xref rid="aff17" ref-type="aff">⬡</xref>
                </contrib>
                <contrib contrib-type="author" id="ath31">
                  <name>
                    <surname>Perrin</surname>
                    <given-names>Catherine</given-names>
                  </name>
                  <xref rid="aff18" ref-type="aff">⬢</xref>
                </contrib>
                <contrib contrib-type="author" id="ath32">
                  <name>
                    <surname>Bich-Muracciole</surname>
                    <given-names>Claudia</given-names>
                  </name>
                  <xref rid="aff18" ref-type="aff">⬢</xref>
                </contrib>
                <contrib contrib-type="author" id="ath33">
                  <name>
                    <surname>Barbas</surname>
                    <given-names>Coral</given-names>
                  </name>
                  <xref rid="aff19" ref-type="aff">◇</xref>
                </contrib>
                <contrib contrib-type="author" id="ath34">
                  <name>
                    <surname>Gonzálvez</surname>
                    <given-names>Ángeles
López</given-names>
                  </name>
                  <xref rid="aff19" ref-type="aff">◇</xref>
                </contrib>
                <contrib contrib-type="author" id="ath35">
                  <name>
                    <surname>Guttman</surname>
                    <given-names>Andras</given-names>
                  </name>
                  <xref rid="aff20" ref-type="aff">◆</xref>
                  <xref rid="aff21" ref-type="aff">⬠</xref>
                  <xref rid="aff22" ref-type="aff">$</xref>
                </contrib>
                <contrib contrib-type="author" id="ath36">
                  <name>
                    <surname>Szigeti</surname>
                    <given-names>Marton</given-names>
                  </name>
                  <xref rid="aff20" ref-type="aff">◆</xref>
                  <xref rid="aff21" ref-type="aff">⬠</xref>
                </contrib>
                <contrib contrib-type="author" id="ath37">
                  <name>
                    <surname>Britz-McKibbin</surname>
                    <given-names>Philip</given-names>
                  </name>
                  <xref rid="aff23" ref-type="aff">%</xref>
                </contrib>
                <contrib contrib-type="author" id="ath38">
                  <name>
                    <surname>Kroezen</surname>
                    <given-names>Zachary</given-names>
                  </name>
                  <xref rid="aff23" ref-type="aff">%</xref>
                </contrib>
                <contrib contrib-type="author" id="ath39">
                  <name>
                    <surname>Shanmuganathan</surname>
                    <given-names>Meera</given-names>
                  </name>
                  <xref rid="aff23" ref-type="aff">%</xref>
                </contrib>
                <contrib contrib-type="author" id="ath40">
                  <name>
                    <surname>Nemes</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <xref rid="aff24" ref-type="aff">&amp;</xref>
                </contrib>
                <contrib contrib-type="author" id="ath41">
                  <name>
                    <surname>Portero</surname>
                    <given-names>Erika P.</given-names>
                  </name>
                  <xref rid="aff24" ref-type="aff">&amp;</xref>
                </contrib>
                <contrib contrib-type="author" id="ath42">
                  <name>
                    <surname>Hankemeier</surname>
                    <given-names>Thomas</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">†</xref>
                </contrib>
                <contrib contrib-type="author" id="ath43">
                  <name>
                    <surname>Codesido</surname>
                    <given-names>Santiago</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">‡</xref>
                  <xref rid="aff3" ref-type="aff">§</xref>
                </contrib>
                <contrib contrib-type="author" id="ath44">
                  <name>
                    <surname>González-Ruiz</surname>
                    <given-names>Víctor</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">‡</xref>
                  <xref rid="aff3" ref-type="aff">§</xref>
                  <xref rid="aff25" ref-type="aff">⊙</xref>
                </contrib>
                <contrib contrib-type="author" id="ath45">
                  <name>
                    <surname>Rudaz</surname>
                    <given-names>Serge</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">‡</xref>
                  <xref rid="aff3" ref-type="aff">§</xref>
                  <xref rid="aff25" ref-type="aff">⊙</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" id="ath46">
                  <name>
                    <surname>Ramautar</surname>
                    <given-names>Rawi</given-names>
                  </name>
                  <xref rid="cor2" ref-type="other">*</xref>
                  <xref rid="aff1" ref-type="aff">†</xref>
                </contrib>
                <aff id="aff1"><label>†</label>Division
of Systems Biomedicine and Pharmacology, Leiden Academic Centre for
Drug Research, <institution>Leiden University</institution>, 2311 G Leiden, <country>The Netherlands</country></aff>
                <aff id="aff2"><label>‡</label>School
of Pharmaceutical Sciences, <institution>University of
Geneva</institution>, Rue Michel Servet 1, 1211 4 Geneva, <country>Switzerland</country></aff>
                <aff id="aff3"><label>§</label>Institute
of Pharmaceutical Sciences of Western Switzerland, <institution>University of Geneva</institution>, Rue Michel Servet 1, 1211 4 Geneva, <country>Switzerland</country></aff>
                <aff id="aff4"><label>∥</label>Laboratory
for the Analysis of Medicines, Center for Interdisciplinary Research
on Medicines (CIRM), <institution>University of Liège</institution>, Avenue Hippocrate 15, B-4000 Liège, <country>Belgium</country></aff>
                <aff id="aff5"><label>⊥</label>Department
of Clinical Chemistry, Center for Interdisciplinary Research on Medicines
(CIRM), <institution>University of Liège</institution>, Avenue Hippocrate 15, B-4000 Liège, <country>Belgium</country></aff>
                <aff id="aff6"><label>@</label><institution>Leiden University
Medical Center</institution>, Center for Proteomics
and Metabolomics, 2300 RC Leiden, <country>The Netherlands</country></aff>
                <aff id="aff7"><label>⊖</label>School
of Geography Earth and Environmental Sciences, <institution>University of Birmingham</institution>, Edgbaston, Birmingham B15 2TT, <country>U.K.</country></aff>
                <aff id="aff8"><label>⦶</label><institution>AB
Sciex UK Ltd</institution>, Phoenix House, Lakeside Drive, Warrington, Cheshire WA1 1RX, <country>U.K.</country></aff>
                <aff id="aff9"><label>□</label><institution>Agilent
Technologies R&amp;D and Marketing GmbH &amp; Co. KG</institution>, Hewlett-Packard-Straße 8, 76337 Waldbronn, <country>Germany</country></aff>
                <aff id="aff10"><label>■</label><institution>AB Sciex</institution>, Landwehrstrasse
54, 64293 Darmstadt, <country>Germany</country></aff>
                <aff id="aff11"><label>○</label><institution>Université Paris-Saclay</institution>, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, <country>France</country></aff>
                <aff id="aff12"><label>●</label><institution>Institut Universitaire de France</institution>, 1 Rue Descartes, 75231 CEDEX 05 Paris, <country>France</country></aff>
                <aff id="aff13"><label>△</label>Laboratoire
de Spectromètrie de Masse des Interactions et des Systémes
(LSMIS) UMR 7140 (Unistra-CNRS), <institution>Université
de Strasbourg</institution>, 4 Rue Blaise Pascal, 67081 CEDEX Strasbourg, <country>France</country></aff>
                <aff id="aff14"><label>▲</label>Institut
de Chimie Organique et Analytique (ICOA), CNRS FR 2708 - UMR 7311, <institution>Université d’Orléans</institution>, 45067 Orléans, <country>France</country></aff>
                <aff id="aff15"><label>▽</label><institution>Centre de Biophysique Moléculaire,
CNRS-Université
d’Orléans, UPR 4311</institution>, 45071 CEDEX 2 Orléans, <country>France</country></aff>
                <aff id="aff16"><label>▼</label>Institute
of Clinical Biochemistry, <institution>Innsbruck Medical
University</institution>, Innrain 80-82, A-6020 Innsbruck, <country>Austria</country></aff>
                <aff id="aff17"><label>⬡</label>Faculty
of Chemistry, <institution>Aalen University</institution>, Beethovenstraße 1, 73430 Aalen, <country>Germany</country></aff>
                <aff id="aff18"><label>⬢</label>Institut
des Biomolécules Max Mousseron (IBMM), UMR 5247-CNRS-UM-ENSCM, <institution>Université de Montpellier</institution>, 34093 CEDEX 5 Montpellier, <country>France</country></aff>
                <aff id="aff19"><label>◇</label>Centre
for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry
and Biochemistry, Facultad de Farmacia, <institution>Universidad San Pablo-CEU, CEU Universities, Urbanización
Montepríncipe</institution>, Boadilladel
Monte 28660, Madrid, <country>Spain</country></aff>
                <aff id="aff20"><label>◆</label>Horváth
Csaba Memorial Laboratory of Bioseparation Sciences, Research Center
for Molecular Medicine, Faculty of Medicine, Doctoral School of Molecular
Medicine, <institution>University of Debrecen</institution>, 98 Nagyerdei Road, H-4032 Debrecen, <country>Hungary</country></aff>
                <aff id="aff21"><label>⬠</label>Translation
Glycomics Group, Research Institute of Biomolecular and Chemical Engineering, <institution>University of Pannonia</institution>, 10 Egyetem Street, Veszprem H-8200, <country>Hungary</country></aff>
                <aff id="aff22"><label>$</label><institution>Sciex</institution>, 250 South Kraemer Boulevard, Brea, California 92821, <country>United States</country></aff>
                <aff id="aff23"><label>%</label>Department
of Chemistry and Chemical Biology, <institution>McMaster
University</institution>, 1280 Main St. W., Hamilton, Ontario L8S 4M1, <country>Canada</country></aff>
                <aff id="aff24"><label>&amp;</label>Department
of Chemistry &amp; Biochemistry, <institution>University
of Maryland</institution>, College
Park, Maryland 20742, <country>United States</country></aff>
                <aff id="aff25"><label>⊙</label><institution>Swiss Centre for Applied Human Toxicology
(SCAHT)</institution>, Missionsstrasse
64, 4055 Bâle, <country>Switzerland</country></aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>*</label>Address: Leiden Academic Centre
for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333
CC, Leiden, The Netherlands. Email: <email>n.f.p.drouin@lacdr.leidenuniv.nl</email>.</corresp>
                <corresp id="cor2"><label>*</label>Address: Leiden Academic
Centre
for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333
CC, Leiden, The Netherlands, Email: <email>r.ramautar@lacdr.leidenuniv.nl</email>. Tel: <phone>+31-71-5276805</phone>.</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>22</day>
                <month>09</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <day>20</day>
                <month>10</month>
                <year>2020</year>
              </pub-date>
              <volume>92</volume>
              <issue>20</issue>
              <fpage>14103</fpage>
              <lpage>14112</lpage>
              <history>
                <date date-type="received">
                  <day>22</day>
                  <month>07</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>22</day>
                  <month>09</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <copyright-statement/>
                <copyright-year>2020</copyright-year>
                <copyright-holder>American Chemical Society</copyright-holder>
                <license>
                  <license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p>
                </license>
              </permissions>
              <abstract>
                <p content-type="toc-graphic">
                  <graphic xlink:href="ac0c03129_0005" id="ab-tgr1"/>
                </p>
                <p>Capillary zone electrophoresis-mass
spectrometry (CE-MS) is a mature
analytical tool for the efficient profiling of (highly) polar and
ionizable compounds. However, the use of CE-MS in comparison to other
separation techniques remains underrepresented in metabolomics, as
this analytical approach is still perceived as technically challenging
and less reproducible, notably for migration time. The latter is key
for a reliable comparison of metabolic profiles and for unknown biomarker
identification that is complementary to high resolution MS/MS. In
this work, we present the results of a Metabo-ring trial involving
16 CE-MS platforms among 13 different laboratories spanning two continents.
The goal was to assess the reproducibility and identification capability
of CE-MS by employing effective electrophoretic mobility (μ<sub>eff</sub>) as the key parameter in comparison to the relative migration
time (RMT) approach. For this purpose, a representative cationic metabolite
mixture in water, pretreated human plasma, and urine samples spiked
with the same metabolite mixture were used and distributed for analysis
by all laboratories. The μ<sub>eff</sub> was determined for
all metabolites spiked into each sample. The background electrolyte
(BGE) was prepared and employed by each participating lab following
the same protocol. All other parameters (capillary, interface, injection
volume, voltage ramp, temperature, capillary conditioning, and rinsing
procedure, etc.) were left to the discretion of the contributing laboratories.
The results revealed that the reproducibility of the μ<sub>eff</sub> for 20 out of the 21 model compounds was below 3.1% vs 10.9% for
RMT, regardless of the huge heterogeneity in experimental conditions
and platforms across the 13 laboratories. Overall, this Metabo-ring
trial demonstrated that CE-MS is a viable and reproducible approach
for metabolomics.</p>
              </abstract>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>document-id-old-9</meta-name>
                  <meta-value>ac0c03129</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>document-id-new-14</meta-name>
                  <meta-value>ac0c03129</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>ccc-price</meta-name>
                  <meta-value/>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <p id="sec1">The state-of-the-art MS instrumentation
used in metabolomics typically provides a read-out of thousands of
molecular features in a given biological sample within a single run
when rigorous data filtering is not applied to reject a large fraction
of spurious signals, redundant ions, and background contaminants.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> The annotation of these features to specific
compounds is currently one of the key challenges in metabolomics and
is often performed using library-based approaches, corresponding to
annotation at various confidence levels according to international
guidelines (e.g., Metabolomics Society).<sup><xref ref-type="bibr" rid="ref2">2</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> Ideally, only parameters presenting good
reproducibility and low bias, such as exact mass, should be used and
crossed to reach high identification confidence.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref6">6</xref></sup> However,
other important parameters, such as retention time in LC, may lack
consistency from one laboratory to another due to the difficulty to
standardize all the operating parameters. This is particularly the
case for the analysis of polar compounds using HILIC conditions where
the chemistry and the age of the column, as well as the injection
solvent and sample matrix including the preparation of the mobile
phase, may yield variable conditions in separation. To tackle this
challenge, several laboratories have resorted to experimentally building
metabolomic libraries for compound identification purposes in house,
an often time-consuming and relatively expensive effort.</p>
            <p>Capillary
zone electrophoresis (CE) coupled to mass spectrometry
(MS) is highly suited for the profiling of polar and charged metabolites,
notably for compound classes such as nucleotides, sugar phosphates,
organic acids, nucleosides, and amino acids.<sup><xref ref-type="bibr" rid="ref7">7</xref>−<xref ref-type="bibr" rid="ref13">13</xref></sup> In metabolomics, the use of CE-MS is considerably underrepresented
in comparison to other analytical techniques.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Over the past few years, various research groups have shown the
utility of CE-MS for biomarker discovery studies using both large
and small sample sets. For example, Harada et al. assessed the long-term
performance of CE-MS for metabolic profiling of more than 8000 human
plasma samples from the Tsuruoka Metabolomics Cohort Study over a
52-month period.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Mischak and co-workers
have profiled native peptides in more than 20,000 human urine samples
by CE-MS with an acceptable interlaboratory reproducibility.<sup><xref ref-type="bibr" rid="ref17">17</xref>−<xref ref-type="bibr" rid="ref20">20</xref></sup> Onjiko et al. used CE-MS to phenotype cell types in single cells
of developing frog embryos.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> Very recently,
CE-MS has shown good mutual agreement (mean bias &lt; 15%) for reliable
quantification of various plasma/serum metabolites and fatty acids
as compared to reversed-phase LC-MS and GC-MS.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> Overall, all these studies demonstrate the usefulness and added
value of CE-MS in the field of metabolomics. However, the separation
science community still perceives this analytical technique as technically
challenging and less reproducible, especially in terms of migration
time among comparative metabolic profiling studies using gas and liquid
chromatography.<sup><xref ref-type="bibr" rid="ref24">24</xref>−<xref ref-type="bibr" rid="ref26">26</xref></sup></p>
            <p>Migration-time reproducibility is of utmost
importance for reliable
metabolomics. It aids comparison of metabolic profiles, including
scrutinizing samples for subtle changes in profiles/patterns in comparative
metabolomics studies, and facilitates the identification of unknown
metabolites. In CE-MS analysis, variability in migration time arises
from fluctuations in the electro-osmotic flow (EOF), temperature,
physicochemical properties of solvents and the capillary, often due
to frequently matrix-induced capillary surface interactions, among
other factors. In contrast to chromatographic-based separation techniques,
(open-access or commercial) software tools for effectively correcting
shifts in migration times are still lacking, despite a high need to
improve overall data robustness for enhancing analytical robustness.
Nemes et al. employed nonlinear time warping to reduce relative errors
from ∼5–10% to ∼0.3% for migration times, thus
substantially aiding metabolite identifications.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> More recently, González-Ruiz et al. tackled this
challenge by developing a software, called ROMANCE, which converts
the migration time scale into an effective electrophoretic mobility
(μ<sub>eff</sub>) scale.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> The approach
demonstrated effective correction of EOF-caused shifts in migration
times, albeit in a small cohort of samples, thus being able to improve
the reproducibility of the migration index below 1.5%. The use of
μ<sub>eff</sub> raises the potential to aid compound identification
in biological samples, notably when using metabolite libraries of
electrophoretic mobilities. Such chemical libraries prove especially
useful in CE, where migration times may exhibit higher variability.</p>
            <p>In 2018, Drouin et al. published the first μ<sub>eff</sub> database for 458 endogenous metabolites,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> as well as its use to identify compounds across different laboratories.
However, the utility of this approach was examined only by a single
individual responsible for preparing the BGE and analyzing the samples
in two different laboratories. On the basis of this study, we present
the results of the Metabo-ring study in which μ<sub>eff</sub> on migration-time reproducibility and identification capability
in CE-MS-based metabolomics was assessed. The study encompassed 13
independent laboratories from academia and companies spanning 11 countries
of 2 continents. All participants used the same batch of samples,
consisting of a representative metabolite mixture, human plasma and
urine (both matrices used at zero-, five- and 10-fold diluted form)
spiked with the same representative metabolite mixture. Each participating
lab prepared and employed the same background electrolyte (BGE) on
the basis of a protocol. All other parameters (capillary, interface,
injection volume, voltage ramp, temperature, type of instrument used,
and capillary conditioning and rinsing procedures, etc.) were left
to the discretion of the participating laboratories. The key parameters
assessed by this Metabo-ring were the reproducibility of relative
migration time (RMT) and the μ<sub>eff</sub> across the laboratories,
which was determined for a representative set of cationic metabolites
in each sample.</p>
            <sec id="sec2">
              <title>Experimental Section</title>
              <sec id="sec2.1">
                <title>Chemicals</title>
                <p>Acetonitrile
(MeCN) and dichloromethane were
purchased from Actu-All Chemicals (Oss, The Netherlands) and Biosolves
(Valkenswaard, The Netherlands), respectively. Spermine, thiamine,
choline, tryptamine, creatine, L-neopterin, trans-4-hydroxy-<sc>l</sc>-proline, and inosine were obtained from Sigma-Aldrich (Steinheim,
Germany). <sc>l</sc>-arginine, <sc>l</sc>-isoleucine, <sc>l</sc>-leucine, <sc>l</sc>-tryptophan, <sc>l</sc>-proline, <sc>l</sc>-glutamine, <sc>l</sc>-lysine, histamine, adenosine and procaine were supplied from
Fluka (Buchs, Switzerland). Agmatine, adenine, and serotonin were
purchased from Alfa Aesar (Kandel, Germany). Paracetamol and nicotine
were obtained from Dr. Ehrenstorfer (Augsburg, Germany) and Carl Roth
(Karlsruhe, Germany), respectively. MS-grade water was provided through
a Milli-Q Advantage A10 water purification system (Merck, Darmstadt,
Germany).</p>
              </sec>
              <sec id="sec2.2">
                <title>Study Design</title>
                <p>The goal of this study was to assess the
migration-time reproducibility of CE-MS for metabolomics and determine
the most suitable approach for metabolite annotation by comparing
RMT versus μ<sub>eff</sub> in standardized condition of BGE.
Changes in BGE composition (and thus pH and ionic strength) are one
of the main sources of variability in separation in CE across laboratories.
BGE in CE-MS-based metabolomics studies often use volatile buffers
such as ammonium acetate/formate, acetic acid, and formic acid.<sup><xref ref-type="bibr" rid="ref30">30</xref>−<xref ref-type="bibr" rid="ref32">32</xref></sup> Over the past few years, the use of 10% acetic acid gained interest
for the efficient profiling of cationic metabolites by CE-MS.<sup><xref ref-type="bibr" rid="ref33">33</xref>−<xref ref-type="bibr" rid="ref35">35</xref></sup> This BGE is relatively easy to prepare and does not require pH adjustment.
Moreover, in comparison to formic acid based BGE, it generates low
CE currents, making it more suitable for the sheathless interface
and also interesting for anionic metabolic profiling due to its slightly
higher pH.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> Though it is not a strict buffer
solution, this BGE can be used the whole day for analyses. Although
the replenishment of the BGE is recommended before each analysis batch,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> it has been shown that 10% acetic acid can be
conserved over an extended period, giving consistent μ<sub>eff</sub>.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Therefore, the present work adopted
10% acetic acid (pH ∼ 2.2) as the BGE, which was prepared independently
in each participating laboratory.</p>
                <p>For maximal impact, this interlaboratory
study involved 20 different CE-MS platforms across 17 different laboratories.
Each laboratory was provided with a set of 7 samples, including one
cationic mix of 23 compounds in water (21 cationic metabolites and
2 internal standards, <xref rid="notes1" ref-type="notes">Table S1</xref>) and six
samples prepared by mixing the standard solution with different levels
of matrices extracted from human plasma and urine subjected to null,
5- and 10-fold dilution, separately. All the samples included paracetamol
and procaine as markers for EOF time. To facilitate adoptability,
our goal was to minimize or avoid modifications to routine practices
of each lab by providing a freedom in experimental conditions and
CE-MS instruments used, thereby making this study design unique in
comparison to previous ring trials.<sup><xref ref-type="bibr" rid="ref39">39</xref>−<xref ref-type="bibr" rid="ref41">41</xref></sup></p>
                <p>Because μ<sub>eff</sub> is only dependent on the BGE composition,
its preparation and the hydrodynamic injection mode without stacking
were imposed to every participant. Stacking in CE is performed by
changing the sample and/or separation conditions to induce a change
in analyte velocity. In this study, all participants have been requested
to use CE-MS separation conditions without implementing a stacking
procedure, including the use of electrokinetic injection (the latter
being selective to high-mobility compounds). Other parameters, such
as capillary length, capillary diameter, voltage, pressure, or ESI
source parameters, were left to the discretion of each group. For
minimal statistical treatment, every sample was analyzed in technical
triplicates, and the injection order was at the discretion of the
participants. The nature of each sample (i.e., matrix composition
and a neutral marker for EOF time) was communicated to the different
groups to guide procedures in capillary rinsing between runs and total
acquisition time.</p>
              </sec>
              <sec id="sec2.3">
                <title>Samples</title>
                <p>Stock solutions of the analyte
standards were
prepared in water at a concentration of 1 mg/mL. Paracetamol was included
at 3 mg/mL to aid signal detection for marking the EOF time. The stock
solutions were stored at −20 °C until usage. The standards
were prepared by diluting the stock solutions in water to 20 μg/mL
for every compound, except paracetamol (30 μg/mL). Pooled human
plasma was obtained from Sanquin (Amsterdam, The Netherlands). In
2 mL Eppendorf tubes with 500 μL plasma, 1000 μL of MeCN
was added for protein precipitation, assisted by shaking for 5 min
at 12000<italic>g</italic> on an orbital shaking table. After centrifugation
at 12000<italic>g</italic> for 5 min at 4 °C, 1800 μL of
supernatant was later collected from each tube and combined together.
The combined supernatant was then split into aliquots of 1800 μL,
which were evaporated to dryness using a SpeedVac and reconstituted
with 600 μL of the standard solution. Dichloromethane (400 μL)
was mixed with 500 μL of the reconstituted samples. After agitation
for 5 min, 450 μL of the aqueous phase was collected and filtered
through centrifugal ultrafilters with a 3 kDa cutoff membrane from
Millipore (Milford, MA, USA) at 12,000<italic>g</italic> for 2 h at
4 °C. The filtrates from different tubes were combined together.
The resulting contaminant’s concentrations (excluding lipids
and proteins) of this solution were supposed to be identical to the
raw plasma. Five- and ten-time dilutions of this filtrate were prepared
via dilution using the water-based standard solution. Finally, the
three samples containing different levels of extracted plasma matrix
were split into 100 μL aliquots and stored at −80 °C
until shipment over dry ice.</p>
                <p>The pooled urine samples were obtained
from a group of healthy volunteers. In order to produce a sufficient
number of samples, multiple aliquots were prepared in parallel. Briefly,
1000 μL of pooled urine was evaporated to dryness with a SpeedVac
and then reconstituted with the standard solution in water. The reconstituted
samples were ultrafiltrated through a 3 kDa cutoff membrane at 12,000<italic>g</italic> for 2 h at 4 °C, followed by the merging of all the
filtered solutions. The resulting solution contains the same contaminant
content as raw urine. Five- and ten-time dilutions were prepared similarly
as plasma-based samples via dilution in the standard solution. Finally,
the three urine-based samples were split into 100 μL aliquots
and stored at −80 °C until shipment in dry ice.</p>
              </sec>
              <sec id="sec2.4">
                <title>BGE Preparation</title>
                <p>Every participating laboratory used
10% acetic acid as the BGE, prepared following the same protocol to
aid reproducibility. Briefly, approximately 80 mL of MS grade water
was first added in a 100 mL volumetric flask, followed by the addition
of 10.00 mL acetic acid (MS grade). The BGE preparation was completed
by further adding water until the gauge line.</p>
              </sec>
              <sec id="sec2.5">
                <title>Instrumentation</title>
                <p>Seventeen laboratories, with 20 different
CE-MS platforms in total, were involved in this interlaboratory study,
of which 11 systems employed a sheath–liquid (SL) interface
and 9 employed a sheathless interface for coupling CE to MS. Among
them, 10 platforms used a sheath–liquid interface based on
a coaxial tube interface from Agilent Technologies. Except for one
platform using CESI 8000 plus capillary electrophoresis system with
a sheathless CE–ESI interface, all the other platforms with
a coaxial sheath-flow ESI interface used a custom-built CE-ESI platform
or the Agilent 7100 capillary electrophoresis system (Agilent Technologies,
Waldbronn, Germany). The SL interface was compatible with a large
variety of operational conditions, therefore a variety of protocols
were used during this study. Fused silica capillary with internal
diameters of 40 or 50 μm and different lengths (from 60 to 105
cm) were used with the sheath–liquid interface across the laboratories.
During this study, each lab used their own (preferred) sheath–liquid
composition and flow-rate. The sheath–liquid-based CE systems
were coupled to various types of mass spectrometers from different
manufacturers, namely, the 6510, 6540, 6550, 6560 QTOF, 6230 TOF,
and 6490 QqQ from Agilent (Santa Clara, CA) as well as the Impact
HD and maXis-3G QTOFMS from Bruker (Bremen, Germany). The other CE-MS
system consisted of a homemade CE system and a custom-built low-flow
sheath–liquid interface coupled to a Bruker Impact HD QTOF
(Bremen, Germany). On this platform a fused silica capillary of 40
μm internal diameter and 105 cm length was used,<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> and the flow-rate of the sheath–liquid was 0.6 μL/min,
whereas in commercial sheath–liquid interfaces, the sheath–liquid
is typically provided at a flow rate in the range from 3 to 10 μL/min.</p>
                <p>The remaining 9 platforms made use of a sheathless interface with
a porous tip, which was coupled to MS via a Nanospray source. This
interface obtained from AB Sciex (Brea, CA), employed a silica capillary
with a 30 μm internal diameter and a 91 cm length and required
a CESI 8000 plus capillary electrophoresis system also provided by
AB Sciex. The CESI interface is compatible with a large variety of
nanoESI sources. Consequently, in addition to AB Sciex mass spectrometers
(TripleTOF 6600, 5600, QTrap 6500, 6500 plus QQQ), the CESI interface
has been used during this study on some other MS brands, such as Bruker
(MicrOTOF-Q II and Impact quadrupole time-of-flight) and Thermo Fisher
(Q-Exactive HF). Whereas the sheath–liquid interfaces were
used with short ramp up of voltage (from 1 to 0.5 min), due to its
original design, the sheathless interface required longer voltage
ramps for the sake of current stability (from 1 to 2 min). Apart from
the large variety of instrumentation used, each laboratory used their
own capillary conditioning and washing procedure. Both capillary and
room temperatures used during analyses by different laboratories ranged
from 20 to 25 °C. More details about the experimental conditions
used with each platform are given in <xref rid="notes1" ref-type="notes">Table S2</xref>.</p>
              </sec>
              <sec id="sec2.6">
                <title>Data Processing</title>
                <p>Initially, 17 groups were involved
in this Metabo-ring trial. One data set was triaged as peak widths
about 5 min at baseline were obtained which is unusual for capillary
electrophoretic separations of small molecules. Therefore, this data
set was excluded from further data processing. The primary MS data
were received and centralized as manufacturer raw data and processed
using Skyline.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> The data files from Bruker
instruments were converted into mzML format using MSConvert<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> prior to their import into Skyline.</p>
                <p>For
robust and transposable results from one laboratory to another, a
two-marker conversion was used for μ<sub>eff</sub> determination
using an in-house software. Paracetamol (μ<sub>eff</sub> = 0
mm<sup>2</sup> kV<sup>–1</sup> min<sup>–2</sup>) and
procaine (μ<sub>eff</sub> = 1559 mm<sup>2</sup> kV<sup>–1</sup> min<sup>–1</sup>) were used as references for μ<sub>eff</sub> calculation.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup> For accurate μ<sub>eff</sub> measurements, the migration time has to be considered from
the start of voltage application. Therefore, when necessary, the migration
time was corrected to synchronize the MS acquisition with the voltage
start. For the same purpose, the voltage ramps have also been considered
during the conversion into mobility.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> RMTs
were calculated using procaine as a reference compound. Bias represents
the deviation of a measured value (<italic>X</italic><sub>m</sub>)
(here RMT or μ<sub>eff</sub>) to a reference (<italic>X</italic><sub>r</sub>). For this purpose, the average μ<sub>eff</sub> and RMT (<xref rid="notes1" ref-type="notes">Table S1</xref>) values measured from
standard solution were used as reference or baseline value for bias
calculation (<xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>).<disp-formula id="eq1"><graphic xlink:href="ac0c03129_m001" position="anchor"/><label>1</label></disp-formula>When possible, leucine and isoleucine were
processed as two distinct peaks, otherwise the same values were attributed
to both compounds.</p>
              </sec>
            </sec>
            <sec id="sec3">
              <title>Results and Discussions</title>
              <sec id="sec3.1">
                <title>Relevance of Standardization
of BGE Preparation</title>
                <p>The
present work adopted 10% acetic acid (pH ∼ 2.2) as the BGE,
which was prepared independently in each participating laboratory. <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> shows an electropherogram
obtained for the analysis of a standard mixture of cationic metabolites
by sheath–liquid CE-MS using 10% acetic acid as BGE, clearly
indicating that a high separation efficiency is provided by the use
of this BGE.</p>
                <fig id="fig1" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Typical profile obtained for the analysis of a standard
mixture
of cationic metabolites by CE-MS (platform 19, see <xref rid="notes1" ref-type="notes">Table S2</xref>) using 10% acetic acid as BGE.</p>
                  </caption>
                  <graphic xlink:href="ac0c03129_0001" id="gr1" position="float"/>
                </fig>
                <p>Repeatability and reproducibility were quantified based on the
data collected from 19 CE-MS platforms (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). The intralaboratory repeatability of the
measurements of both μ<sub>eff</sub> and RMT was typically below
1% for the test compounds in water for three consecutive analyses.
The average reproducibility of these parameters was about 4.3% and
5.7%, respectively, with a maximum observed for inosine in both cases.
Therefore, these findings clearly indicate the presence of a significant
contribution of the interlaboratory variability, leading to higher
values of relative standard deviation (RSD) for reproducibility. To
find the main source for the observed variation, we determined the
bias of each compound as measured by each individual analytical platform. <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> reveals a relatively
high degree of variation, especially for the slower-migrating compounds
(longer migration times). This is expected since for a constant measurement
uncertainty, the relative error increases as the reference values
get closer to 0, as it is the case in the μ<sub>eff</sub> scale
(<xref rid="notes1" ref-type="notes">Table S1</xref>).</p>
                <fig id="fig2" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Individual bias to the average and interlaboratory
reproducibility
of μ<sub>eff</sub> as obtained for the analysis of cationic
metabolite standards by 19 CE-MS platforms. Green and red lines mark
bias thresholds at ±5 and ±10%, respectively. Metabolites
are presented in decreasing mobility order from left to right.</p>
                  </caption>
                  <graphic xlink:href="ac0c03129_0002" id="gr2" position="float"/>
                </fig>
                <p>Interestingly, three data sets presented a lower
μ<sub>eff</sub> for the late-migrating compounds (i.e., <sc>l</sc>-isoleucine, <sc>l</sc>-leucine, <sc>l</sc>-tryptophan, <sc>l</sc>-glutamine, <sc>l</sc>-proline, <sc>l</sc>-neopterin, trans-4-hydroxyproline,
and
inosine) as compared to the data obtained by the other 16 CE-MS platforms
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Since μ<sub>eff</sub> is theoretically influenced by the physicochemical properties
of the BGE only, this phenomenon was explained by variation in BGE
preparation. Indeed, slow-migrating cationic compounds usually present
a low electrical charge due to their basic functions with low p<italic>K</italic><sub>a</sub> or due to presence of an acidic function with
high p<italic>K</italic><sub>a</sub>. Consequently, their μ<sub>eff</sub> is greatly influenced by any slight variation of the acidity
of the BGE. Therefore, with a p<italic>K</italic><sub>a</sub> of 2.74,
inosine was the slowest compound and also the compound with a relatively
high μ<sub>eff</sub> variability. Consequently, results from
these 3 platforms were triaged from further data analysis in the rest
of the study (<xref rid="notes1" ref-type="notes">Table S2</xref>).</p>
              </sec>
              <sec id="sec3.2">
                <title>Effective Electrophoretic
Mobility vs Relative Migration Time</title>
                <p>It is relatively feasible
to mitigate variations in migration time
resulting from the BGE with added control over buffer composition.
While it is possible to control suction effect from the ionization
source, it may be difficult to tackle the adsorption of matrix components
onto the inner capillary wall.<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref48">48</xref></sup> To correct for these sources of variability, the most popular method
is the use of RMT.<sup><xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref49">49</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> This approach consists of comparing the velocity of the analyte
(<italic>v</italic><sub>analyte</sub>) to that of an internal standard
(IS) (<italic>v</italic><sub>IS</sub>). Both velocities are explained
by the electrophoretic movement of BGE and their electrophoretic movement
(μ<sub>EOF</sub> and μ<sub>eff</sub>, respectively) under
an electric field (<italic>E</italic>) as well as the hydrodynamic
movement of the BGE (<italic>v</italic><sub>hydrodynamic</sub>), such
siphoning between the position of the inlet and the outlet of the
CE capillary tip, the sheath flow surrounding of the CE capillary
in the <xref rid="notes1" ref-type="notes">ESI</xref> source, the close-by vacuum of
the atmospheric interface of the mass spectrometer, and pressure that
may be applied during the separation. As expressed in <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>, the hydrodynamic phenomena exert
an additive effect instead of a proportional one and, therefore, they
cannot be accurately corrected by a ratio approach, making the RMT
approach intrinsically incorrect.<disp-formula id="eq2"><graphic xlink:href="ac0c03129_m002" position="anchor"/><label>2</label></disp-formula>A correction based on RMT can be powerful
for compounds migrating in proximity to the IS as they are subject
to the same variation of the hydrodynamic phenomenon. However, this
approach has limited ability to correct the migration of compounds
far from the IS.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> On the other hand, μ<sub>eff</sub> depends on the hydrodynamic radius (<italic>r</italic>),
the ionic charge of the compounds (<italic>q</italic>), and the viscosity
of the BGE (η) (<xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>).<disp-formula id="eq3"><graphic xlink:href="ac0c03129_m003" position="anchor"/><label>3</label></disp-formula>Therefore, μ<sub>eff</sub> is independent
of BGE velocity and is only influenced by its physicochemical properties.
This parameter is measurable using a neutral marker combined with
the experimental conditions. In this study, we have chosen for a conversion
based on two markers (c.a. procaine and paracetamol) in order to obtain
μ<sub>eff</sub> values which are independent of the operational
conditions across the laboratories, such as capillary length, electric
field, and temperature.<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup></p>
                <p>Indeed, our measurements
confirmed the viability of using μ<sub>eff</sub> as depicted
in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>; the μ<sub>eff</sub> presented a bias below 3.1% for all compounds except for
inosine, while for the same set of metabolites, RMT showed bias up
to 11%. For compounds such as tryptophan, μ<sub>eff</sub> presented
a variation up to 5-times lower than the corresponding RMT. Interestingly,
while the reproducibility of μ<sub>eff</sub> remained stable
in a range from 0.8 to 3.1% for compounds with high and medium μ<sub>eff</sub>, RMTs trended with migration time. Indeed, as shown in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B, minimal dispersion
of the RMT values was observed for the compounds with migration time
similar to that of the IS, whereas metabolites with extreme RMT presented
with a high interlaboratory variability.</p>
                <fig id="fig3" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p>Individual bias and interlaboratory
variability of μ<sub>eff</sub> (A) and RMT (B) as determined
for the analysis of standard
metabolite mixture by 16 CE-MS platforms. The green and red lines
denote a 5% and 10% threshold, respectively. Metabolites are presented
in decreasing mobility order from left to right.</p>
                  </caption>
                  <graphic xlink:href="ac0c03129_0003" id="gr3" position="float"/>
                </fig>
                <p>As the approach using the in-house metabolite library is based
on the relative error to a reference value (i.e., the average μ<sub>eff</sub>), it is important to observe the bias of each parameter.
As shown in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, excluding inosine, 98% of the μ<sub>eff</sub> measurements
are within a 5% bias limit, while 6 platforms presented RMT outside
those limits (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B), with the maximal bias up to 28%. These results confirm the theoretical
normalization power of the μ<sub>eff</sub> conversion of MT
in comparison to RMT, especially in the context of creating an interlaboratory
database.</p>
              </sec>
              <sec id="sec3.3">
                <title>Influence of Sample Composition</title>
                <p>High chemical complexity
in plasma and urine are known to challenge molecular identifications
and quantification due to matrix effects as well as instrument performance
and longevity. In CZE, it is well-known that the ionic strength in
the sample zone influences the migration speed of the compounds at
the start of the separation. Therefore, high salt concentrations in
such complex biological samples can lead to lower signal-to-noise
ratios due to peak broadening and distortions in peak shapes and shifts
in migration indices (migration time, RMT, and μ<sub>eff</sub>).</p>
                <p>While a “dilute and shoot” approach is viable
for urine, deproteinization is usually necessary for plasma performed
before analysis as preventive measures. Deproteinization is mostly
performed in organic solvents (e.g., methanol or acetonitrile), followed
by rigorous vortex shaking and an evaporation-to-dryness of the supernatant
after which the dried extract is reconstituted into an appropriate
solvent and volume for the follow-up instrumental analysis.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> However, these purification steps do not adequately
address high salt content in urine and plasma.</p>
                <p>To evaluate the
influence of sample conductivity, samples with
different dilutions of urine and plasma matrices were analyzed. These
concentrations represented an equivalent of undiluted, 5- and 10-times
dilution of the biological fluids. As shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, the μ<sub>eff</sub> reproducibility
remained globally unaffected irrespective of the type and concentration
of the biological matrix. However, some trends of bias can be observed
when platforms are considered individually for each metabolite. Fast-migrating
compounds (e.g., spermine, histamine, agmatine, and nicotine) presented
a bias up to 18% in both undiluted plasma and urine samples (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A,B). As highlighted
in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C,E and
D,F for μ<sub>eff</sub> and RMT, respectively, these deviations
to the baseline decrease with concentration of the matrix (see the
dilution factor).</p>
                <fig id="fig4" position="float">
                  <label>Figure 4</label>
                  <caption>
                    <p>Individual bias and interlaboratory variability of μ<sub>eff</sub> for cationic metabolites in complex biological matrixes:
plasma (A, C, and E) and urine (B, D, and F) at three different concentrations
(undiluted: A and B; 5-times dilution: C and D; 10-times dilution:
E and F) by 16 CE-MS platforms. Metabolites are presented in decreasing
mobility order from left to right.</p>
                  </caption>
                  <graphic xlink:href="ac0c03129_0004" id="gr4" position="float"/>
                </fig>
                <p>We explain these variations by deformations of the peak for the
4 fastest-migrating metabolites. With migration in a close proximity
to the sodium peak, these compounds experience peak broadening. In
some extreme cases, the ion suppression induced by sodium can suppress
a part of the peak leading to an incorrect detection of its apex (see <xref rid="notes1" ref-type="notes">Figure S1</xref>). As shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C,E, with the exception of inosine, 15 platforms
presented a bias below 5% and one with a bias below 7% in 5-times
diluted plasma. Further dilution of the samples (10-times) led to
bias below 5% for all platform and compounds, except for inosine due
to slight variation in BGE composition as discussed above. Concerning
urine, results were highly similar to only one CE platform presenting
a bias above 5% from samples diluted 5-fold, excluding inosine. However,
as shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>F, one platform presented higher deviation for spermine compared
to more concentrated samples (Figure D). No explanation has been found
so far to explain this deviation in the 10-fold diluted samples while
no drift was observed in the 5-fold dilution of urine.</p>
              </sec>
              <sec id="sec3.4">
                <title>Proposed: Metabolite
Identification Guidelines Based on a Common
Library</title>
                <p>This work demonstrated the utility of an interlaboratory
CE-MS database to enhance metabolomics. With the use of standardized
BGE conditions (10% acetic acid here), conversion from migration times
to μ<sub>eff</sub> was found to efficiently normalize separation
between 13 different laboratories with interlaboratory variability
below 3.1% for 20 of the 21 compounds considered.</p>
                <p>For sake of
comparison with gold standard in feature annotation in metabolomics,
collisional cross section are among the most reproducible parameters
with interlaboratory variation in the range of 2%<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> and 5% and are usually the threshold for
identification confirmation.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> Although HILIC is a
powerful method to separate polar compounds, deviation of the retention
time up to 10% to in-house databases are usually considered for feature
annotation.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
                <p>As a first approach,
we propose that such a scoring system can
be based on different ranges of bias between μ<sub>eff</sub> measurements and μ<sub>eff</sub> values in databases (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Such databases
should be built on a reliable manner, taking into consideration multiple
technical replicates, performed in multiple laboratories, and involving
different instruments. Using 10% acetic acid as the BGE, the deviation
to the consensus value below 10% was easily achieved for most metabolites
in complex biological matrices. By using a system suitability test
based on a short panel of compounds with different migration speeds,
we envision it possible to test the BGE and assess whether it is performing
conformed to the database. For example, our data here exemplified
μ<sub>eff</sub> measurements with a bias below 5%, thus provided
an added piece of information to credential compounds and aid identifications
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Further,
credentialing may consider electrophoretic migration for added fidelity.</p>
                <table-wrap id="tbl1" position="float">
                  <label>Table 1</label>
                  <caption>
                    <title>Proposition of Confidence Levels for
Annotation of Features Using μ<sub>eff</sub> by CE-MS</title>
                  </caption>
                  <table frame="hsides" rules="groups" border="0">
                    <colgroup>
                      <col align="left"/>
                      <col align="left"/>
                      <col align="left"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th style="border:none;" align="center">confidence
level</th>
                        <th style="border:none;" align="center">&gt;100 mm<sup>2</sup> kV<sup>–1</sup> min<sup>–1</sup></th>
                        <th style="border:none;" align="center">&lt;100 mm<sup>2</sup> kV<sup>–1</sup> min<sup>–1</sup></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td style="border:none;" align="left">high</td>
                        <td style="border:none;" align="left">&lt;5%</td>
                        <td style="border:none;" align="left">&lt;10% or ±10</td>
                      </tr>
                      <tr>
                        <td style="border:none;" align="left">medium</td>
                        <td style="border:none;" align="left">5% &lt; <italic>x</italic> &lt; 10%</td>
                        <td style="border:none;" align="left">10% &lt; <italic>x</italic> &lt; 20% or ±20</td>
                      </tr>
                      <tr>
                        <td style="border:none;" align="left">low (rejected hypothesis)</td>
                        <td style="border:none;" align="left">&gt;10%</td>
                        <td style="border:none;" align="left">&gt;20% or &gt; ±20</td>
                      </tr>
                    </tbody>
                  </table>
                </table-wrap>
                <p>As the mobility of slow-migrating compounds is more
dependent on
the differences of physicochemical properties of the BGE, conversion
to μ<sub>eff</sub> overestimates relative bias and reproducibility.
For instance, in the case of inosine, μ<sub>eff</sub> presented
a considerably low absolute deviation on all platforms with a maximum
deviation about ±10 mm<sup>2</sup> kV<sup>–1</sup> min<sup>–1</sup> (<xref rid="notes1" ref-type="notes">Table S1</xref>). Therefore,
the use of absolute thresholds in μ<sub>eff</sub><sup><xref ref-type="bibr" rid="ref29">29</xref></sup> may enhance identification confidence for slow-migrating
metabolites. In the presence of standardized experimental conditions,
the normalization to and absolute use of μ<sub>eff</sub> appears
to provide an added piece of compound-dependent information to aid
the identification of metabolites.</p>
                <p>Next to the μ<sub>eff</sub>, this study also highlights the
annotation capability of RMT, comparable to retention time in HILIC.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Although the use of RMT shows interlaboratory
variability and bias below 10% for a very large majority of the compounds
and platforms, it has to be used cautiously since few platforms presented
very large deviations (up to 30%).</p>
              </sec>
            </sec>
            <sec id="sec4">
              <title>Conclusions</title>
              <p>This
study encompassing 13 laboratories and 16 platforms spanning
11 countries and 2 continents found CE-MS a robust and reproducible
technology for metabolomics. Despite major variations in experimental
conditions, CE instruments and methods, CE-ESI ion sources, and even
users, conversion of migration times into μ<sub>eff</sub> reduced
variability from 10.9% on RMT to 3.1% in the μ<sub>eff</sub> scale using the same BGE composition. Tabulating μ<sub>eff</sub> under specific BGE compositions into universal database adds another
compound-dependent and reliable value, thus complementing traditional
MS-MS/MS databases in metabolomics (e.g., HMDB<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> and Metlin<sup><xref ref-type="bibr" rid="ref56">56</xref></sup>). The use of μ<sub>eff</sub> requires only a limited number of internal standards (e.g.,
two different compounds used here) while substantially enhancing compound
identification in metabolomics via a targeted or untargeted approach.
On the basis of these results, we propose here guidelines by using
a scoring approach based on different μ<sub>eff</sub> criteria
to support feature annotation in metabolomics. Although this study
focused on cationic small molecules only, we anticipate that this
approach also is easily extendable to anionic metabolites, including
but not limited to small organic acids, nucleotides, and sugar phosphates.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> As LC-based separations are often challenged
for such compounds, we anticipate this Metabo-ring trial to invigorate
the use of CE-MS with the μ<sub>eff</sub>-based approach in
metabolomics and other fields.</p>
            </sec>
          </body>
          <back>
            <notes id="notes1" notes-type="si">
              <title>Supporting Information Available</title>
              <p>The Supporting Information is
available free of charge at <ext-link ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.analchem.0c03129?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c03129</ext-link>.<list id="silist" list-type="simple"><list-item><p>(Table S1) Physicochemical
properties of the metabolites
of interest (*: from ChemAxon, <uri xlink:href="http://chemicalize.com">chemicalize.com</uri>, consulted the 16th of July 2020) and (Figure
S1) extracted ion electropherograms of spermine (<italic>m</italic>/<italic>z</italic> 203.2230) in nondiluted plasma samples obtained
by CE-MS across 5 different laboratories (<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.analchem.0c03129/suppl_file/ac0c03129_si_001.pdf">PDF</ext-link>)</p></list-item><list-item><p>(Table S2) Detailed CE-MS parameters
(<ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.analchem.0c03129/suppl_file/ac0c03129_si_002.xlsx">XLSX</ext-link>)</p></list-item></list></p>
            </notes>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="sifile1">
                <media xlink:href="ac0c03129_si_001.pdf">
                  <caption>
                    <p>ac0c03129_si_001.pdf</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="sifile2">
                <media xlink:href="ac0c03129_si_002.xlsx">
                  <caption>
                    <p>ac0c03129_si_002.xlsx</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
            <notes notes-type="" id="notes2">
              <title>Author Contributions</title>
              <p><sup>#</sup> N.D. and M.v.M. contributed equally. The manuscript was written through
contributions of all authors. All authors have given approval to the
final version of the manuscript.</p>
            </notes>
            <notes notes-type="COI-statement" id="notes3">
              <p>The authors
declare no competing financial interest.</p>
            </notes>
            <ack>
              <title>Acknowledgments</title>
              <p>The Vidi grant scheme of The Netherlands Organization
of Scientific Research (NWO Vidi 723.016.003) is acknowledged for
the financial support of a part of this Metabo-ring study and for
the financial support of M.v.M. and W.Z. N.D. acknowledges the financial
support from Horizon 2020 Marie Sklodowska-Curie CO-FUND (Grant Agreement
no: 707404). P.N. acknowledges support from the National Science Foundation
(award IOS-1832968), the National Institute of Health (R35GM124755),
and the Arnold and Mabel Beckman Foundation (Young Investigator Grant).
A.J.C., I.L., and J.A.T. acknowledge the European Commission via Horizon
2020 project ACEnano (Grant H2020-NMBP-2016-720952). P.B.-M. acknowledges
funding from the Natural Sciences and Engineering Research Council
of Canada and Genome Canada. M.S. and A.G. gratefully acknowledge
the grants of the National Research, Development and Innovation Office
(NN127062, 2018-2.1.17-TÉT-KR-2018-00010). This work was also
sponsored by the BIONANO_GINOP-2.3.2-15-2016-00017 project. This is
contribution #173 from the Horváth Csaba Memorial Laboratory
of Bioseparation Sciences. A.L. would like to acknowledge the CNRS
(UMR 7140), University of Strasbourg. G.A.H.D.B., C.C., and R.N. would
like to thank the Région Centre Val de Loire and the Labex
SynOrg (ANR-11- LABX-0029) for financial support. Á.L.G. and
C.B. acknowledge the Ministry of Science, Innovation and Universities
of Spain and FEDER funds (MICINN) (ref. RTI2018-095166-B-I00), and
the Autonomous Community of Madrid (NOVELREN-CM. ref: B2017/BMD3751).
S.C. greatly acknowledges the Swiss National Science Foundation through
Grant 31003A_166658. F.G. is acknowledged for technical assistance
and for her help with shipment of the samples. AB Sciex and Agilent
Technologies are acknowledged for their technical support.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="ref1">
                <mixed-citation publication-type="journal" id="cit1"><name><surname>Mahieu</surname><given-names>N. G.</given-names></name>; <name><surname>Patti</surname><given-names>G. J.</given-names></name><source>Anal. Chem.</source><year>2017</year>, <volume>89</volume>, <fpage>10397</fpage>–<lpage>10406</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.7b02380</pub-id>.<pub-id pub-id-type="pmid">28914531</pub-id></mixed-citation>
              </ref>
              <ref id="ref2">
                <mixed-citation publication-type="journal" id="cit2"><name><surname>van
Rijswijk</surname><given-names>M.</given-names></name>; <name><surname>Beirnaert</surname><given-names>C.</given-names></name>; <name><surname>Caron</surname><given-names>C.</given-names></name>; <name><surname>Cascante</surname><given-names>M.</given-names></name>; <name><surname>Dominguez</surname><given-names>V.</given-names></name>; <name><surname>Dunn</surname><given-names>W. B.</given-names></name>; <name><surname>Ebbels</surname><given-names>T. M. D.</given-names></name>; <name><surname>Giacomoni</surname><given-names>F.</given-names></name>; <name><surname>Gonzalez-Beltran</surname><given-names>A.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name>; <name><surname>Haug</surname><given-names>K.</given-names></name>; <name><surname>Izquierdo-Garcia</surname><given-names>J. L.</given-names></name>; <name><surname>Jimenez</surname><given-names>R. C.</given-names></name>; <name><surname>Jourdan</surname><given-names>F.</given-names></name>; <name><surname>Kale</surname><given-names>N.</given-names></name>; <name><surname>Klapa</surname><given-names>M. I.</given-names></name>; <name><surname>Kohlbacher</surname><given-names>O.</given-names></name>; <name><surname>Koort</surname><given-names>K.</given-names></name>; <name><surname>Kultima</surname><given-names>K.</given-names></name>; <name><surname>Le Corguille</surname><given-names>G.</given-names></name>; et al. <source>F1000Research</source><year>2017</year>, <volume>6</volume>, <fpage>1649</fpage><pub-id pub-id-type="doi">10.12688/f1000research.12342.1</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref3">
                <mixed-citation publication-type="journal" id="cit3"><name><surname>Rochat</surname><given-names>B.</given-names></name><source>J. Am. Soc. Mass
Spectrom.</source><year>2017</year>, <volume>28</volume>, <fpage>709</fpage>–<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1007/s13361-016-1556-0</pub-id>.<pub-id pub-id-type="pmid">28116700</pub-id></mixed-citation>
              </ref>
              <ref id="ref4">
                <mixed-citation publication-type="journal" id="cit4"><name><surname>Damont</surname><given-names>A.</given-names></name>; <name><surname>Olivier</surname><given-names>M.-F.</given-names></name>; <name><surname>Warnet</surname><given-names>A.</given-names></name>; <name><surname>Lyan</surname><given-names>B.</given-names></name>; <name><surname>Pujos-Guillot</surname><given-names>E.</given-names></name>; <name><surname>Jamin</surname><given-names>E. L.</given-names></name>; <name><surname>Debrauwer</surname><given-names>L.</given-names></name>; <name><surname>Bernillon</surname><given-names>S.</given-names></name>; <name><surname>Junot</surname><given-names>C.</given-names></name>; <name><surname>Tabet</surname><given-names>J.-C.</given-names></name>; <name><surname>Fenaille</surname><given-names>F.</given-names></name><source>J. Mass Spectrom.</source><year>2019</year>, <volume>54</volume>, <fpage>567</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1002/jms.4372</pub-id>.<pub-id pub-id-type="pmid">31083780</pub-id></mixed-citation>
              </ref>
              <ref id="ref5">
                <mixed-citation publication-type="journal" id="cit5"><name><surname>Nash</surname><given-names>W. J.</given-names></name>; <name><surname>Dunn</surname><given-names>W. B.</given-names></name><source>TrAC, Trends Anal. Chem.</source><year>2019</year>, <volume>120</volume>, <fpage>115324</fpage><pub-id pub-id-type="doi">10.1016/j.trac.2018.11.022</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref6">
                <mixed-citation publication-type="journal" id="cit6"><name><surname>Bergé</surname><given-names>M.</given-names></name>; <name><surname>Pezzatti</surname><given-names>J.</given-names></name>; <name><surname>González-Ruiz</surname><given-names>V.</given-names></name>; <name><surname>Degeorges</surname><given-names>L.</given-names></name>; <name><surname>Mottet-Osman</surname><given-names>G.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>Viollier</surname><given-names>P. H.</given-names></name><source>eLife</source><year>2020</year>, <volume>9</volume>, <fpage>9</fpage><pub-id pub-id-type="doi">10.7554/eLife.52272</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref7">
                <mixed-citation publication-type="journal" id="cit7"><name><surname>Soga</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>Y.</given-names></name>; <name><surname>Ueno</surname><given-names>Y.</given-names></name>; <name><surname>Naraoka</surname><given-names>H.</given-names></name>; <name><surname>Tomita</surname><given-names>M.</given-names></name>; <name><surname>Nishioka</surname><given-names>T.</given-names></name><source>J. Proteome Res.</source><year>2003</year>, <volume>2</volume>, <fpage>488</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1021/pr034020m</pub-id>.<pub-id pub-id-type="pmid">14582645</pub-id></mixed-citation>
              </ref>
              <ref id="ref8">
                <mixed-citation publication-type="journal" id="cit8"><name><surname>Soga</surname><given-names>T.</given-names></name>; <name><surname>Baran</surname><given-names>R.</given-names></name>; <name><surname>Suematsu</surname><given-names>M.</given-names></name>; <name><surname>Ueno</surname><given-names>Y.</given-names></name>; <name><surname>Ikeda</surname><given-names>S.</given-names></name>; <name><surname>Sakurakawa</surname><given-names>T.</given-names></name>; <name><surname>Kakazu</surname><given-names>Y.</given-names></name>; <name><surname>Ishikawa</surname><given-names>T.</given-names></name>; <name><surname>Robert</surname><given-names>M.</given-names></name>; <name><surname>Nishioka</surname><given-names>T.</given-names></name>; <name><surname>Tomita</surname><given-names>M.</given-names></name><source>J. Biol. Chem.</source><year>2006</year>, <volume>281</volume>, <fpage>16768</fpage>–<lpage>16776</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M601876200</pub-id>.<pub-id pub-id-type="pmid">16608839</pub-id></mixed-citation>
              </ref>
              <ref id="ref9">
                <mixed-citation publication-type="journal" id="cit9"><name><surname>Barbas</surname><given-names>C.</given-names></name>; <name><surname>Moraes</surname><given-names>E. P.</given-names></name>; <name><surname>Villasenor</surname><given-names>A.</given-names></name><source>J. Pharm. Biomed.
Anal.</source><year>2011</year>, <volume>55</volume>, <fpage>823</fpage>–<lpage>831</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2011.02.001</pub-id>.<pub-id pub-id-type="pmid">21376499</pub-id></mixed-citation>
              </ref>
              <ref id="ref10">
                <mixed-citation publication-type="journal" id="cit10"><name><surname>Baidoo</surname><given-names>E. E.</given-names></name>; <name><surname>Benke</surname><given-names>P. I.</given-names></name>; <name><surname>Neususs</surname><given-names>C.</given-names></name>; <name><surname>Pelzing</surname><given-names>M.</given-names></name>; <name><surname>Kruppa</surname><given-names>G.</given-names></name>; <name><surname>Leary</surname><given-names>J. A.</given-names></name>; <name><surname>Keasling</surname><given-names>J. D.</given-names></name><source>Anal. Chem.</source><year>2008</year>, <volume>80</volume>, <fpage>3112</fpage>–<lpage>3122</lpage>. <pub-id pub-id-type="doi">10.1021/ac800007q</pub-id>.<pub-id pub-id-type="pmid">18384203</pub-id></mixed-citation>
              </ref>
              <ref id="ref11">
                <mixed-citation publication-type="journal" id="cit11"><name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name><source>Methods Mol. Biol.</source><year>2011</year>, <volume>708</volume>, <fpage>229</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61737-985-7_14</pub-id>.<pub-id pub-id-type="pmid">21207294</pub-id></mixed-citation>
              </ref>
              <ref id="ref12">
                <mixed-citation publication-type="journal" id="cit12"><name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Guled</surname><given-names>F.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name>; <name><surname>Ramautar</surname><given-names>R.</given-names></name><source>Electrophoresis</source><year>2020</year>, <volume>41</volume>, <fpage>360</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201900417</pub-id>.<pub-id pub-id-type="pmid">31907937</pub-id></mixed-citation>
              </ref>
              <ref id="ref13">
                <mixed-citation publication-type="journal" id="cit13"><name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Pezzatti</surname><given-names>J.</given-names></name>; <name><surname>Gagnebin</surname><given-names>Y.</given-names></name>; <name><surname>Gonzalez-Ruiz</surname><given-names>V.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name><source>Anal. Chim. Acta</source><year>2018</year>, <volume>1032</volume>, <fpage>178</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2018.05.063</pub-id>.<pub-id pub-id-type="pmid">30143215</pub-id></mixed-citation>
              </ref>
              <ref id="ref14">
                <mixed-citation publication-type="journal" id="cit14"><name><surname>Kuehnbaum</surname><given-names>N. L.</given-names></name>; <name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name><source>Chem. Rev.</source><year>2013</year>, <volume>113</volume>, <fpage>2437</fpage>–<lpage>2468</lpage>. <pub-id pub-id-type="doi">10.1021/cr300484s</pub-id>.<pub-id pub-id-type="pmid">23506082</pub-id></mixed-citation>
              </ref>
              <ref id="ref15">
                <mixed-citation publication-type="journal" id="cit15"><name><surname>Miggiels</surname><given-names>P.</given-names></name>; <name><surname>Wouters</surname><given-names>B.</given-names></name>; <name><surname>van Westen</surname><given-names>G. J. P.</given-names></name>; <name><surname>Dubbelman</surname><given-names>A.-C.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name><source>TrAC, Trends Anal. Chem.</source><year>2019</year>, <volume>120</volume>, <fpage>115323</fpage><pub-id pub-id-type="doi">10.1016/j.trac.2018.11.021</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref16">
                <mixed-citation publication-type="journal" id="cit16"><name><surname>Harada</surname><given-names>S.</given-names></name>; <name><surname>Hirayama</surname><given-names>A.</given-names></name>; <name><surname>Chan</surname><given-names>Q.</given-names></name>; <name><surname>Kurihara</surname><given-names>A.</given-names></name>; <name><surname>Fukai</surname><given-names>K.</given-names></name>; <name><surname>Iida</surname><given-names>M.</given-names></name>; <name><surname>Kato</surname><given-names>S.</given-names></name>; <name><surname>Sugiyama</surname><given-names>D.</given-names></name>; <name><surname>Kuwabara</surname><given-names>K.</given-names></name>; <name><surname>Takeuchi</surname><given-names>A.</given-names></name>; <name><surname>Akiyama</surname><given-names>M.</given-names></name>; <name><surname>Okamura</surname><given-names>T.</given-names></name>; <name><surname>Ebbels</surname><given-names>T. M. D.</given-names></name>; <name><surname>Elliott</surname><given-names>P.</given-names></name>; <name><surname>Tomita</surname><given-names>M.</given-names></name>; <name><surname>Sato</surname><given-names>A.</given-names></name>; <name><surname>Suzuki</surname><given-names>C.</given-names></name>; <name><surname>Sugimoto</surname><given-names>M.</given-names></name>; <name><surname>Soga</surname><given-names>T.</given-names></name>; <name><surname>Takebayashi</surname><given-names>T.</given-names></name><source>PLoS One</source><year>2018</year>, <volume>13</volume>, <elocation-id>e0191230</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0191230</pub-id>.<pub-id pub-id-type="pmid">29346414</pub-id></mixed-citation>
              </ref>
              <ref id="ref17">
                <mixed-citation publication-type="journal" id="cit17"><name><surname>Klein</surname><given-names>J.</given-names></name>; <name><surname>Bascands</surname><given-names>J. L.</given-names></name>; <name><surname>Mischak</surname><given-names>H.</given-names></name>; <name><surname>Schanstra</surname><given-names>J. P.</given-names></name><source>Kidney Int.</source><year>2016</year>, <volume>89</volume>, <fpage>539</fpage>–<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2015.10.010</pub-id>.<pub-id pub-id-type="pmid">26880450</pub-id></mixed-citation>
              </ref>
              <ref id="ref18">
                <mixed-citation publication-type="journal" id="cit18"><person-group><name><surname>Boizard</surname><given-names>F.</given-names></name>; <name><surname>Brunchault</surname><given-names>V.</given-names></name>; <name><surname>Moulos</surname><given-names>P.</given-names></name>; <name><surname>Breuil</surname><given-names>B.</given-names></name>; <name><surname>Klein</surname><given-names>J.</given-names></name>; <name><surname>Lounis</surname><given-names>N.</given-names></name>; <name><surname>Caubet</surname><given-names>C.</given-names></name>; <name><surname>Tellier</surname><given-names>S.</given-names></name>; <name><surname>Bascands</surname><given-names>J. L.</given-names></name>; <name><surname>Decramer</surname><given-names>S.</given-names></name>; <name><surname>Schanstra</surname><given-names>J. P.</given-names></name>; <name><surname>Buffin-Meyer</surname><given-names>B.</given-names></name></person-group><source>Sci. Rep.</source><year>2016</year>, <volume>6</volume>, <pub-id pub-id-type="doi">10.1038/srep34453</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref19">
                <mixed-citation publication-type="journal" id="cit19"><name><surname>Siwy</surname><given-names>J.</given-names></name>; <name><surname>Zurbig</surname><given-names>P.</given-names></name>; <name><surname>Argiles</surname><given-names>A.</given-names></name>; <name><surname>Beige</surname><given-names>J.</given-names></name>; <name><surname>Haubitz</surname><given-names>M.</given-names></name>; <name><surname>Jankowski</surname><given-names>J.</given-names></name>; <name><surname>Julian</surname><given-names>B. A.</given-names></name>; <name><surname>Linde</surname><given-names>P. G.</given-names></name>; <name><surname>Marx</surname><given-names>D.</given-names></name>; <name><surname>Mischak</surname><given-names>H.</given-names></name>; <name><surname>Mullen</surname><given-names>W.</given-names></name>; <name><surname>Novak</surname><given-names>J.</given-names></name>; <name><surname>Ortiz</surname><given-names>A.</given-names></name>; <name><surname>Persson</surname><given-names>F.</given-names></name>; <name><surname>Pontillo</surname><given-names>C.</given-names></name>; <name><surname>Rossing</surname><given-names>P.</given-names></name>; <name><surname>Rupprecht</surname><given-names>H.</given-names></name>; <name><surname>Schanstra</surname><given-names>J. P.</given-names></name>; <name><surname>Vlahou</surname><given-names>A.</given-names></name>; <name><surname>Vanholder</surname><given-names>R.</given-names></name><source>Nephrol., Dial.,
Transplant</source><year>2017</year>, <volume>32</volume>, <fpage>2079</fpage>–<lpage>2089</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfw337</pub-id>.<pub-id pub-id-type="pmid">27984204</pub-id></mixed-citation>
              </ref>
              <ref id="ref20">
                <mixed-citation publication-type="journal" id="cit20"><name><surname>Pontillo</surname><given-names>C.</given-names></name>; <name><surname>Mischak</surname><given-names>H.</given-names></name><source>Clin. Kidney J.</source><year>2017</year>, <volume>10</volume>, <fpage>192</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1093/ckj/sfx002</pub-id>.<pub-id pub-id-type="pmid">28694965</pub-id></mixed-citation>
              </ref>
              <ref id="ref21">
                <mixed-citation publication-type="journal" id="cit21"><name><surname>Onjiko</surname><given-names>R. M.</given-names></name>; <name><surname>Moody</surname><given-names>S. A.</given-names></name>; <name><surname>Nemes</surname><given-names>P.</given-names></name><source>Proc. Natl. Acad.
Sci. U. S. A.</source><year>2015</year>, <volume>112</volume>, <fpage>6545</fpage>–<lpage>6550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1423682112</pub-id>.<pub-id pub-id-type="pmid">25941375</pub-id></mixed-citation>
              </ref>
              <ref id="ref22">
                <mixed-citation publication-type="journal" id="cit22"><name><surname>Azab</surname><given-names>S.</given-names></name>; <name><surname>Ly</surname><given-names>R.</given-names></name>; <name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name><source>Anal. Chem.</source><year>2019</year>, <volume>91</volume>, <fpage>2329</fpage>–<lpage>2336</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.8b05054</pub-id>.<pub-id pub-id-type="pmid">30570251</pub-id></mixed-citation>
              </ref>
              <ref id="ref23">
                <mixed-citation publication-type="journal" id="cit23"><name><surname>Wild</surname><given-names>J.</given-names></name>; <name><surname>Shanmuganathan</surname><given-names>M.</given-names></name>; <name><surname>Hayashi</surname><given-names>M.</given-names></name>; <name><surname>Potter</surname><given-names>M.</given-names></name>; <name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name><source>Analyst</source><year>2019</year>, <volume>144</volume>, <fpage>6595</fpage>–<lpage>6608</lpage>. <pub-id pub-id-type="doi">10.1039/C9AN01642B</pub-id>.<pub-id pub-id-type="pmid">31608347</pub-id></mixed-citation>
              </ref>
              <ref id="ref24">
                <mixed-citation publication-type="journal" id="cit24"><name><surname>Buscher</surname><given-names>J. M.</given-names></name>; <name><surname>Czernik</surname><given-names>D.</given-names></name>; <name><surname>Ewald</surname><given-names>J. C.</given-names></name>; <name><surname>Sauer</surname><given-names>U.</given-names></name>; <name><surname>Zamboni</surname><given-names>N.</given-names></name><source>Anal. Chem.</source><year>2009</year>, <volume>81</volume>, <fpage>2135</fpage>–<lpage>2143</lpage>. <pub-id pub-id-type="doi">10.1021/ac8022857</pub-id>.<pub-id pub-id-type="pmid">19236023</pub-id></mixed-citation>
              </ref>
              <ref id="ref25">
                <mixed-citation publication-type="journal" id="cit25"><name><surname>Begou</surname><given-names>O.</given-names></name>; <name><surname>Gika</surname><given-names>H. G.</given-names></name>; <name><surname>Wilson</surname><given-names>I. D.</given-names></name>; <name><surname>Theodoridis</surname><given-names>G.</given-names></name><source>Analyst</source><year>2017</year>, <volume>142</volume>, <fpage>3079</fpage>–<lpage>3100</lpage>. <pub-id pub-id-type="doi">10.1039/C7AN00812K</pub-id>.<pub-id pub-id-type="pmid">28792021</pub-id></mixed-citation>
              </ref>
              <ref id="ref26">
                <mixed-citation publication-type="journal" id="cit26"><name><surname>Coulier</surname><given-names>L.</given-names></name>; <name><surname>Bas</surname><given-names>R.</given-names></name>; <name><surname>Jespersen</surname><given-names>S.</given-names></name>; <name><surname>Verheij</surname><given-names>E.</given-names></name>; <name><surname>van der Werf</surname><given-names>M. J.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name><source>Anal. Chem.</source><year>2006</year>, <volume>78</volume>, <fpage>6573</fpage>–<lpage>6582</lpage>. <pub-id pub-id-type="doi">10.1021/ac0607616</pub-id>.<pub-id pub-id-type="pmid">16970336</pub-id></mixed-citation>
              </ref>
              <ref id="ref27">
                <mixed-citation publication-type="journal" id="cit27"><name><surname>Nemes</surname><given-names>P.</given-names></name>; <name><surname>Knolhoff</surname><given-names>A. M.</given-names></name>; <name><surname>Rubakhin</surname><given-names>S. S.</given-names></name>; <name><surname>Sweedler</surname><given-names>J. V.</given-names></name><source>Anal. Chem.</source><year>2011</year>, <volume>83</volume>, <fpage>6810</fpage>–<lpage>6817</lpage>. <pub-id pub-id-type="doi">10.1021/ac2015855</pub-id>.<pub-id pub-id-type="pmid">21809850</pub-id></mixed-citation>
              </ref>
              <ref id="ref28">
                <mixed-citation publication-type="journal" id="cit28"><name><surname>González-Ruiz</surname><given-names>V.</given-names></name>; <name><surname>Gagnebin</surname><given-names>Y.</given-names></name>; <name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Codesido</surname><given-names>S.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name><source>Electrophoresis</source><year>2018</year>, <volume>39</volume>, <fpage>1222</fpage>–<lpage>1232</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201700427</pub-id>.<pub-id pub-id-type="pmid">29292828</pub-id></mixed-citation>
              </ref>
              <ref id="ref29">
                <mixed-citation publication-type="journal" id="cit29"><name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Pezzatti</surname><given-names>J.</given-names></name>; <name><surname>Gagnebin</surname><given-names>Y.</given-names></name>; <name><surname>Gonzalez-Ruiz</surname><given-names>V.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name><source>Anal. Chim. Acta</source><year>2018</year>, <volume>1032</volume>, <fpage>178</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2018.05.063</pub-id>.<pub-id pub-id-type="pmid">30143215</pub-id></mixed-citation>
              </ref>
              <ref id="ref30">
                <mixed-citation publication-type="journal" id="cit30"><name><surname>Rojo</surname><given-names>D.</given-names></name>; <name><surname>Barbas</surname><given-names>C.</given-names></name>; <name><surname>Lopez-Gonzalvez</surname><given-names>A.</given-names></name><source>Methods Mol. Biol.</source><year>2019</year>, <volume>1859</volume>, <fpage>253</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-8757-3_14</pub-id>.<pub-id pub-id-type="pmid">30421234</pub-id></mixed-citation>
              </ref>
              <ref id="ref31">
                <mixed-citation publication-type="journal" id="cit31"><name><surname>González-Ruiz</surname><given-names>V.</given-names></name>; <name><surname>Codesido</surname><given-names>S.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name><source>Electrophoresis</source><year>2018</year>, <volume>39</volume>, <fpage>853</fpage>–<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201700328</pub-id>.<pub-id pub-id-type="pmid">29124762</pub-id></mixed-citation>
              </ref>
              <ref id="ref32">
                <mixed-citation publication-type="journal" id="cit32"><name><surname>Kuehnbaum</surname><given-names>N. L.</given-names></name>; <name><surname>Kormendi</surname><given-names>A.</given-names></name>; <name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name><source>Anal. Chem.</source><year>2013</year>, <volume>85</volume>, <fpage>10664</fpage>–<lpage>10669</lpage>. <pub-id pub-id-type="doi">10.1021/ac403171u</pub-id>.<pub-id pub-id-type="pmid">24195601</pub-id></mixed-citation>
              </ref>
              <ref id="ref33">
                <mixed-citation publication-type="journal" id="cit33"><person-group><name><surname>Sánchez-López</surname><given-names>E.</given-names></name>; <name><surname>Kammeijer</surname><given-names>G. S. M.</given-names></name>; <name><surname>Crego</surname><given-names>A. L.</given-names></name>; <name><surname>Marina</surname><given-names>M. L.</given-names></name>; <name><surname>Ramautar</surname><given-names>R.</given-names></name>; <name><surname>Peters</surname><given-names>D. J. M.</given-names></name>; <name><surname>Mayboroda</surname><given-names>O. A.</given-names></name></person-group><source>Sci. Rep.</source><year>2019</year>, <volume>9</volume>, <pub-id pub-id-type="doi">10.1038/s41598-018-37512-8</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref34">
                <mixed-citation publication-type="journal" id="cit34"><name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name><source>J. Pharm. Biomed.
Anal.</source><year>2018</year>, <volume>159</volume>, <fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2018.06.029</pub-id>.<pub-id pub-id-type="pmid">29980019</pub-id></mixed-citation>
              </ref>
              <ref id="ref35">
                <mixed-citation publication-type="journal" id="cit35"><name><surname>van
Mever</surname><given-names>M.</given-names></name>; <name><surname>Segers</surname><given-names>K.</given-names></name>; <name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Guled</surname><given-names>F.</given-names></name>; <name><surname>Heyden</surname><given-names>Y. V.</given-names></name>; <name><surname>Van Eeckhaut</surname><given-names>A.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name>; <name><surname>Ramautar</surname><given-names>R.</given-names></name><source>Microchem. J.</source><year>2020</year>, <volume>156</volume>, <fpage>104949</fpage><pub-id pub-id-type="doi">10.1016/j.microc.2020.104949</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref36">
                <mixed-citation publication-type="journal" id="cit36"><person-group person-group-type="allauthors"><name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Mielcarek</surname><given-names>A.</given-names></name>; <name><surname>Wenz</surname><given-names>C.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name></person-group><source>Electrophoresis</source>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="ref37">
                <mixed-citation publication-type="journal" id="cit37"><name><surname>Gulersonmez</surname><given-names>M. C.</given-names></name>; <name><surname>Lock</surname><given-names>S.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name>; <name><surname>Ramautar</surname><given-names>R.</given-names></name><source>Electrophoresis</source><year>2016</year>, <volume>37</volume>, <fpage>1007</fpage>–<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201500435</pub-id>.<pub-id pub-id-type="pmid">26593113</pub-id></mixed-citation>
              </ref>
              <ref id="ref38">
                <mixed-citation publication-type="journal" id="cit38"><person-group person-group-type="allauthors"><name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Gulersonmez</surname><given-names>M. C.</given-names></name>; <name><surname>Hankemeier</surname><given-names>T.</given-names></name>; <name><surname>Ramautar</surname><given-names>R.</given-names></name></person-group><source>Journal of
visualized
experiments: JoVE</source>, <year>2016</year>.</mixed-citation>
              </ref>
              <ref id="ref39">
                <mixed-citation publication-type="journal" id="cit39"><name><surname>Dispas</surname><given-names>A.</given-names></name>; <name><surname>Marini</surname><given-names>R.</given-names></name>; <name><surname>Desfontaine</surname><given-names>V.</given-names></name>; <name><surname>Veuthey</surname><given-names>J. L.</given-names></name>; <name><surname>Kotoni</surname><given-names>D.</given-names></name>; <name><surname>Losacco</surname><given-names>L. G.</given-names></name>; <name><surname>Clarke</surname><given-names>A.</given-names></name>; <name><surname>Muscat Galea</surname><given-names>C.</given-names></name>; <name><surname>Mangelings</surname><given-names>D.</given-names></name>; <name><surname>Jocher</surname><given-names>B. M.</given-names></name>; <name><surname>Regalado</surname><given-names>E. L.</given-names></name>; <name><surname>Plachká</surname><given-names>K.</given-names></name>; <name><surname>Nováková</surname><given-names>L.</given-names></name>; <name><surname>Wuyts</surname><given-names>B.</given-names></name>; <name><surname>François</surname><given-names>I.</given-names></name>; <name><surname>Gray</surname><given-names>M.</given-names></name>; <name><surname>Aubin</surname><given-names>A. J.</given-names></name>; <name><surname>Tarafder</surname><given-names>A.</given-names></name>; <name><surname>Cazes</surname><given-names>M.</given-names></name>; <name><surname>Desvignes</surname><given-names>C.</given-names></name>; et al. <source>J. Pharm. Biomed. Anal.</source><year>2018</year>, <volume>161</volume>, <fpage>414</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2018.08.042</pub-id>.<pub-id pub-id-type="pmid">30216790</pub-id></mixed-citation>
              </ref>
              <ref id="ref40">
                <mixed-citation publication-type="journal" id="cit40"><name><surname>Wenz</surname><given-names>C.</given-names></name>; <name><surname>Barbas</surname><given-names>C.</given-names></name>; <name><surname>Lopez-Gonzalvez</surname><given-names>A.</given-names></name>; <name><surname>Garcia</surname><given-names>A.</given-names></name>; <name><surname>Benavente</surname><given-names>F.</given-names></name>; <name><surname>Sanz-Nebot</surname><given-names>V.</given-names></name>; <name><surname>Blanc</surname><given-names>T.</given-names></name>; <name><surname>Freckleton</surname><given-names>G.</given-names></name>; <name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name>; <name><surname>Shanmuganathan</surname><given-names>M.</given-names></name>; <name><surname>de l’Escaille</surname><given-names>F.</given-names></name>; <name><surname>Far</surname><given-names>J.</given-names></name>; <name><surname>Haselberg</surname><given-names>R.</given-names></name>; <name><surname>Huang</surname><given-names>S.</given-names></name>; <name><surname>Huhn</surname><given-names>C.</given-names></name>; <name><surname>Pattky</surname><given-names>M.</given-names></name>; <name><surname>Michels</surname><given-names>D.</given-names></name>; <name><surname>Mou</surname><given-names>S.</given-names></name>; <name><surname>Yang</surname><given-names>F.</given-names></name>; <name><surname>Neusuess</surname><given-names>C.</given-names></name>; et al. <source>J. Sep.
Sci.</source><year>2015</year>, <volume>38</volume>, <fpage>3262</fpage>–<lpage>3270</lpage>. <pub-id pub-id-type="doi">10.1002/jssc.201500551</pub-id>.<pub-id pub-id-type="pmid">26147246</pub-id></mixed-citation>
              </ref>
              <ref id="ref41">
                <mixed-citation publication-type="journal" id="cit41"><name><surname>Hernández-Mesa</surname><given-names>M.</given-names></name>; <name><surname>D’Atri</surname><given-names>V.</given-names></name>; <name><surname>Barknowitz</surname><given-names>G.</given-names></name>; <name><surname>Fanuel</surname><given-names>M.</given-names></name>; <name><surname>Pezzatti</surname><given-names>J.</given-names></name>; <name><surname>Dreolin</surname><given-names>N.</given-names></name>; <name><surname>Ropartz</surname><given-names>D.</given-names></name>; <name><surname>Monteau</surname><given-names>F.</given-names></name>; <name><surname>Vigneau</surname><given-names>E.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>Stead</surname><given-names>S.</given-names></name>; <name><surname>Rogniaux</surname><given-names>H.</given-names></name>; <name><surname>Guillarme</surname><given-names>D.</given-names></name>; <name><surname>Dervilly</surname><given-names>G.</given-names></name>; <name><surname>Le Bizec</surname><given-names>B.</given-names></name><source>Analytical chemistry</source><year>2020</year>, <volume>92</volume>, <fpage>5013</fpage>–<lpage>5022</lpage>.<pub-id pub-id-type="pmid">32167758</pub-id></mixed-citation>
              </ref>
              <ref id="ref42">
                <mixed-citation publication-type="journal" id="cit42"><name><surname>Portero</surname><given-names>E. P.</given-names></name>; <name><surname>Nemes</surname><given-names>P.</given-names></name><source>Analyst</source><year>2019</year>, <volume>144</volume>, <fpage>892</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1039/C8AN01999A</pub-id>.<pub-id pub-id-type="pmid">30542678</pub-id></mixed-citation>
              </ref>
              <ref id="ref43">
                <mixed-citation publication-type="journal" id="cit43"><name><surname>Onjiko</surname><given-names>R. M.</given-names></name>; <name><surname>Moody</surname><given-names>S. A.</given-names></name>; <name><surname>Nemes</surname><given-names>P.</given-names></name><source>Proc. Natl. Acad.
Sci. U. S. A.</source><year>2015</year>, <volume>112</volume>, <fpage>6545</fpage><pub-id pub-id-type="doi">10.1073/pnas.1423682112</pub-id>.<pub-id pub-id-type="pmid">25941375</pub-id></mixed-citation>
              </ref>
              <ref id="ref44">
                <mixed-citation publication-type="journal" id="cit44"><name><surname>MacLean</surname><given-names>B.</given-names></name>; <name><surname>Tomazela</surname><given-names>D. M.</given-names></name>; <name><surname>Shulman</surname><given-names>N.</given-names></name>; <name><surname>Chambers</surname><given-names>M.</given-names></name>; <name><surname>Finney</surname><given-names>G. L.</given-names></name>; <name><surname>Frewen</surname><given-names>B.</given-names></name>; <name><surname>Kern</surname><given-names>R.</given-names></name>; <name><surname>Tabb</surname><given-names>D. L.</given-names></name>; <name><surname>Liebler</surname><given-names>D. C.</given-names></name>; <name><surname>MacCoss</surname><given-names>M. J.</given-names></name><source>Bioinformatics</source><year>2010</year>, <volume>26</volume>, <fpage>966</fpage>–<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq054</pub-id>.<pub-id pub-id-type="pmid">20147306</pub-id></mixed-citation>
              </ref>
              <ref id="ref45">
                <mixed-citation publication-type="journal" id="cit45"><name><surname>Adusumilli</surname><given-names>R.</given-names></name>; <name><surname>Mallick</surname><given-names>P.</given-names></name><source>Methods Mol. Biol.</source><year>2017</year>, <volume>1550</volume>, <fpage>339</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-6747-6_23</pub-id>.<pub-id pub-id-type="pmid">28188540</pub-id></mixed-citation>
              </ref>
              <ref id="ref46">
                <mixed-citation publication-type="journal" id="cit46"><person-group person-group-type="allauthors"><name><surname>Codesido</surname><given-names>S.</given-names></name>; <name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Ferre</surname><given-names>S.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>González-Ruiz</surname><given-names>V.</given-names></name></person-group><source>ChemRxiv</source>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="ref47">
                <mixed-citation publication-type="journal" id="cit47"><name><surname>Nowak</surname><given-names>P. M.</given-names></name>; <name><surname>Woźniakiewicz</surname><given-names>M.</given-names></name>; <name><surname>Gładysz</surname><given-names>M.</given-names></name>; <name><surname>Janus</surname><given-names>M.</given-names></name>; <name><surname>Kościelniak</surname><given-names>P.</given-names></name><source>Anal. Bioanal. Chem.</source><year>2017</year>, <volume>409</volume>, <fpage>4383</fpage>–<lpage>4393</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-017-0382-y</pub-id>.<pub-id pub-id-type="pmid">28484810</pub-id></mixed-citation>
              </ref>
              <ref id="ref48">
                <mixed-citation publication-type="journal" id="cit48"><name><surname>Lee</surname><given-names>R.</given-names></name>; <name><surname>Ptolemy</surname><given-names>A. S.</given-names></name>; <name><surname>Niewczas</surname><given-names>L.</given-names></name>; <name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name><source>Anal. Chem.</source><year>2007</year>, <volume>79</volume>, <fpage>403</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1021/ac061780i</pub-id>.<pub-id pub-id-type="pmid">17222002</pub-id></mixed-citation>
              </ref>
              <ref id="ref49">
                <mixed-citation publication-type="journal" id="cit49"><name><surname>Sugimoto</surname><given-names>M.</given-names></name>; <name><surname>Hirayama</surname><given-names>A.</given-names></name>; <name><surname>Robert</surname><given-names>M.</given-names></name>; <name><surname>Abe</surname><given-names>S.</given-names></name>; <name><surname>Soga</surname><given-names>T.</given-names></name>; <name><surname>Tomita</surname><given-names>M.</given-names></name><source>Electrophoresis</source><year>2010</year>, <volume>31</volume>, <fpage>2311</fpage>–<lpage>2318</lpage>. <pub-id pub-id-type="doi">10.1002/elps.200900584</pub-id>.<pub-id pub-id-type="pmid">20568260</pub-id></mixed-citation>
              </ref>
              <ref id="ref50">
                <mixed-citation publication-type="journal" id="cit50"><name><surname>Sugimoto</surname><given-names>M.</given-names></name>; <name><surname>Kikuchi</surname><given-names>S.</given-names></name>; <name><surname>Arita</surname><given-names>M.</given-names></name>; <name><surname>Soga</surname><given-names>T.</given-names></name>; <name><surname>Nishioka</surname><given-names>T.</given-names></name>; <name><surname>Tomita</surname><given-names>M.</given-names></name><source>Anal. Chem.</source><year>2005</year>, <volume>77</volume>, <fpage>78</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1021/ac048950g</pub-id>.<pub-id pub-id-type="pmid">15623281</pub-id></mixed-citation>
              </ref>
              <ref id="ref51">
                <mixed-citation publication-type="journal" id="cit51"><name><surname>Li</surname><given-names>X.-F.</given-names></name>; <name><surname>Ren</surname><given-names>H.</given-names></name>; <name><surname>Le</surname><given-names>X.</given-names></name>; <name><surname>Qi</surname><given-names>M.</given-names></name>; <name><surname>Ireland</surname><given-names>I. D.</given-names></name>; <name><surname>Dovichi</surname><given-names>N. J.</given-names></name><source>Journal of Chromatography
A</source><year>2000</year>, <volume>869</volume>, <fpage>375</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9673(99)00893-6</pub-id>.<pub-id pub-id-type="pmid">10720252</pub-id></mixed-citation>
              </ref>
              <ref id="ref52">
                <mixed-citation publication-type="journal" id="cit52"><name><surname>Drouin</surname><given-names>N.</given-names></name>; <name><surname>Rudaz</surname><given-names>S.</given-names></name>; <name><surname>Schappler</surname><given-names>J.</given-names></name><source>Analyst</source><year>2018</year>, <volume>143</volume>, <fpage>16</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1039/C7AN01333G</pub-id>.</mixed-citation>
              </ref>
              <ref id="ref53">
                <mixed-citation publication-type="journal" id="cit53"><name><surname>Stow</surname><given-names>S. M.</given-names></name>; <name><surname>Causon</surname><given-names>T. J.</given-names></name>; <name><surname>Zheng</surname><given-names>X.</given-names></name>; <name><surname>Kurulugama</surname><given-names>R. T.</given-names></name>; <name><surname>Mairinger</surname><given-names>T.</given-names></name>; <name><surname>May</surname><given-names>J. C.</given-names></name>; <name><surname>Rennie</surname><given-names>E. E.</given-names></name>; <name><surname>Baker</surname><given-names>E. S.</given-names></name>; <name><surname>Smith</surname><given-names>R. D.</given-names></name>; <name><surname>McLean</surname><given-names>J. A.</given-names></name>; <name><surname>Hann</surname><given-names>S.</given-names></name>; <name><surname>Fjeldsted</surname><given-names>J. C.</given-names></name><source>Anal. Chem.</source><year>2017</year>, <volume>89</volume>, <fpage>9048</fpage>–<lpage>9055</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.7b01729</pub-id>.<pub-id pub-id-type="pmid">28763190</pub-id></mixed-citation>
              </ref>
              <ref id="ref54">
                <mixed-citation publication-type="journal" id="cit54"><name><surname>Reisdorph</surname><given-names>R.</given-names></name>; <name><surname>Michel</surname><given-names>C.</given-names></name>; <name><surname>Quinn</surname><given-names>K.</given-names></name>; <name><surname>Doenges</surname><given-names>K.</given-names></name>; <name><surname>Reisdorph</surname><given-names>N.</given-names></name><source>Methods Mol. Biol.</source><year>2020</year>, <volume>2084</volume>, <fpage>55</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-0716-0030-6_3</pub-id>.<pub-id pub-id-type="pmid">31729653</pub-id></mixed-citation>
              </ref>
              <ref id="ref55">
                <mixed-citation publication-type="journal" id="cit55"><name><surname>Wishart</surname><given-names>D. S.</given-names></name>; <name><surname>Feunang</surname><given-names>Y. D.</given-names></name>; <name><surname>Marcu</surname><given-names>A.</given-names></name>; <name><surname>Guo</surname><given-names>A. C.</given-names></name>; <name><surname>Liang</surname><given-names>K.</given-names></name>; <name><surname>Vazquez-Fresno</surname><given-names>R.</given-names></name>; <name><surname>Sajed</surname><given-names>T.</given-names></name>; <name><surname>Johnson</surname><given-names>D.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Karu</surname><given-names>N.</given-names></name>; <name><surname>Sayeeda</surname><given-names>Z.</given-names></name>; <name><surname>Lo</surname><given-names>E.</given-names></name>; <name><surname>Assempour</surname><given-names>N.</given-names></name>; <name><surname>Berjanskii</surname><given-names>M.</given-names></name>; <name><surname>Singhal</surname><given-names>S.</given-names></name>; <name><surname>Arndt</surname><given-names>D.</given-names></name>; <name><surname>Liang</surname><given-names>Y.</given-names></name>; <name><surname>Badran</surname><given-names>H.</given-names></name>; <name><surname>Grant</surname><given-names>J.</given-names></name>; <name><surname>Serra-Cayuela</surname><given-names>A.</given-names></name>; et al. <source>Nucleic
Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>D608</fpage>–<lpage>D617</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1089</pub-id>.<pub-id pub-id-type="pmid">29140435</pub-id></mixed-citation>
              </ref>
              <ref id="ref56">
                <mixed-citation publication-type="journal" id="cit56"><name><surname>Smith</surname><given-names>C. A.</given-names></name>; <name><surname>Maille</surname><given-names>G. O.</given-names></name>; <name><surname>Want</surname><given-names>E. J.</given-names></name>; <name><surname>Qin</surname><given-names>C.</given-names></name>; <name><surname>Trauger</surname><given-names>S. A.</given-names></name>; <name><surname>Brandon</surname><given-names>T. R.</given-names></name>; <name><surname>Custodio</surname><given-names>D. E.</given-names></name>; <name><surname>Abagyan</surname><given-names>R.</given-names></name>; <name><surname>Siuzdak</surname><given-names>G.</given-names></name><source>Ther. Drug Monit.</source><year>2005</year>, <volume>27</volume>, <fpage>747</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1097/01.ftd.0000179845.53213.39</pub-id>.<pub-id pub-id-type="pmid">16404815</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
